Form D CCM 22 Fund, LLC
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 4 Redwire Corp For: Jul 03 Filed by: Edmunds Chris
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 40-17F2 J.P. Morgan Exchange-Tra Filed by: J.P. Morgan Exchange-Traded Fund Trust
OMB APPROVAL
OMB Number:
3235-0360
Expires:
December 31, 2026
Estimated average burden
hours per response
2.0
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-17f-2
Certificate of Accounting of Securities and Similar
Investments in the Custody of
Management Investment Companies
Pursuant to Rule 17f-2 [17 CFR 270.17f-2]
1.... (continue reading...)
Form 424B2 GOLDMAN SACHS GROUP INC
Filed Pursuant to Rule 424(b)(2)
Registration Statement No. 333-284538
The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
Subject to Completion. Dated July 7, 2026.
... (continue reading...)
Form 4 Sunrun Inc. For: Jul 06 Filed by: Barak Maria
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
More SEC Filings
View Older Stories-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form PRE 14A Valion Bio, Inc. For: Aug 14
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
-
Form 4 ioneer Ltd For: Jul 02 Filed by: Coon Kenneth D
-
Form 4 Mynd.ai, Inc. For: Jul 02 Filed by: Merle Denise M
-
Form 424B5 Jefferies Financial Grou
-
Form 4 Redwire Corp For: Jul 03 Filed by: Gold Michael N.
-
Form 4 Mynd.ai, Inc. For: Jul 02 Filed by: Mendelson Robin
-
Form 13F-HR Dynamic Advisor Solution For: Jun 30
-
Form 4 Mynd.ai, Inc. For: Jul 02 Filed by: Krause Allyson G.
-
Form 8-K OCEANEERING INTERNATIONA For: Jul 06
-
Form 4 CYTOKINETICS INC For: Jul 07 Filed by: Malik Fady Ibraham
-
Form 4 Mynd.ai, Inc. For: Jul 02 Filed by: Giterman Arthur G.
-
Form 4 Mynd.ai, Inc. For: Jul 02 Filed by: Strand Michael B.
-
Form N-PX IEQ CAPITAL, LLC For: Jun 30
-
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
-
Form 4 Mynd.ai, Inc. For: Jul 02 Filed by: Getz Joel A.
-
Form 4 Mynd.ai, Inc. For: Jul 02 Filed by: Leung Lim Kin Simon
-
Form 4 Redwire Corp For: Jul 03 Filed by: Cannito Peter Anthony Jr
-
Form 4 Mynd.ai, Inc. For: Jul 02 Filed by: Solomon Lance I.
-
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
-
Form 13F-HR FOCUS Wealth Advisors, For: Jun 30
-
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
-
Form D Charism Capital Fund I,
-
Form 40-17F2 J.P. Morgan Exchange-Tra Filed by: J.P. Morgan Exchange-Traded Fund Trust
-
Form 4 Imunon, Inc. For: Jul 02 Filed by: Tardugno Michael H
-
Form 4 Sunrun Inc. For: Jul 06 Filed by: Abajian Danny
-
Form 13F-HR WILLNER & HELLER, LLC For: Jun 30
-
Form 8-K Praxis Precision Medicin For: Jul 07
-
Form N-PX DMKC Advisory Services, For: Jun 30
-
Form 6-K DIANA SHIPPING INC. For: Jul 31
-
Form 3 ADI GLOBAL DISTRIBUTION For: Jul 07 Filed by: Lane Jeannine J
-
Form 13F-HR McNaughton Wealth Manage For: Jun 30
-
Form N-CSRS/A AEGIS FUNDS For: Jun 30
-
Form 4 Pelthos Therapeutics For: Jul 02 Filed by: Friedberg Ezra M
-
Form 485APOS EA Series Trust
-
Form 13F-HR Graves Light Lenhart For: Jun 30
-
Form 4 Pelthos Therapeutics For: Jul 02 Filed by: Pauls Matthew
-
Form 4 OCTAVE SPECIALTY GROUP For: Jul 01 Filed by: Stein Jeffrey Scott
-
Form 8-K Oportun Financial Corp For: Jun 30
-
Form 4 MIAMI INTERNATIONAL HOLD For: Jul 06 Filed by: Gallagher Thomas P.
-
Form 4 Pelthos Therapeutics For: Jul 02 Filed by: Greenleaf Peter
-
Form ABS-15G J.P. Morgan Acceptance For: Jul 07
-
Form 4 Robinhood Markets, Inc. For: Jul 02 Filed by: Quirk Steven M.
-
Form 13F-HR TLWM For: Jun 30
-
Form 425 Pasqal Holding SAS Filed by: Bleichroeder Acquisition France Merger Sub 2
-
Form 4 Block, Inc. For: Jul 02 Filed by: Grassadonia Brian
-
Form 4 OCTAVE SPECIALTY GROUP For: Jul 01 Filed by: PRICE MICHAEL D
-
Form 424B2 GOLDMAN SACHS GROUP INC
